TRV GP V, LLC

Institutional

CIK 0001990717

$401.0M

Reported AUM

Positions

Q1 2026

Period

2026-05-07

Filed

The Brief · TRV GP V, LLC · Q1 2026

AI · grounded in 13F

TRV GP V, LLC reported no changes to its 13F holdings for 2026-03-31 relative to 2025-12-31.

Portfolio · Q1 2026

Top holdings

QoQ vs Q4 2025

#	Stock	Issuer	Price	Day %	1Y Gr.	5Y Gr.	Value	% of book	Δ shares (QoQ)	Status
1	RAPP	RAPPORT THERAPEUTICS, INC.	$36.31	0.58%	185.15%	58.89%	$223.3M	55.68%	—	HELD
2	SEPN	SEPTERNA, INC.	$31.15	-0.70%	205.09%	23.17%	$149.4M	37.25%	—	HELD
3	MAZE	MAZE THERAPEUTICS, INC.	$24.27	-4.45%	87.70%	98.45%	$28.4M	7.08%	—	HELD

Source: SEC EDGAR · accession 0001193125-26-212010. 13F discloses long positions only — shorts, foreign equities, and options are excluded.